Sarmad Sabour, MD
Otolaryngology · Arvada, CONPI 1902007743
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,752 of the $2,502 with a category attached, or 70.0%. 13 manufacturers reported payments, led by Aerin Medical Inc. at 42.0% of the total. Reporting peaked in 2021 at $1,030 and has fallen 86.2% since, to $142 in 2025.
Across 69 payments — averaging $36.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$1K
- Stryker$719
- Optinose US, Inc.$277
- Regeneron Healthcare Solutions, Inc.$90
- Medtronic$75
- GSK$73
- plus $217 from 7 others
What the payments were for
- Speaking & faculty fees$75030%
- Food & beverage$1,75270%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 15 | $1,051 |
| Stryker | 16 | $719 |
| Optinose US, Inc. | 16 | $277 |
| Regeneron Healthcare Solutions, Inc. | 5 | $90 |
| Medtronic | 2 | $75 |
| GSK | 3 | $73 |
| Acclarent, Inc | 4 | $63 |
| Intersect ENT, Inc. | 2 | $38 |
| Neurent Medical Limited | 1 | $32 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Merck | 2 | $26 |
| Lucid Diagnostics Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,502 in reported general payments places this provider in the 70th percentile of 174 otolaryngology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 18 | $2,746 |
| Ipratropium Bromide | 41 | $1,059 |
| Famotidine | 25 | $342 |
| Methylprednisolone | 25 | $249 |
| Omeprazole | 15 | $210 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $174 |
| Prednisone | 33 | $90 |
| Levofloxacin | 20 | $76 |
| Ondansetron OdtOndansetron | 14 | $63 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Arvada
- Justin YanArvada$4K
- Suzanne BertramFort Collins$475K
- Barton KnoxColorado Springs$164K
- Nicholas BeckmannColorado Springs$151K
- Vijay RamakrishnanAurora$128K
- Michael WilhelmColorado Springs$76K
- Andrew WinklerAurora$68K
- David OppermanDenver$67K
- Robert KellerColorado Springs$45K
- Peter SchmidLongmont$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.